Author

Nicole Laferriere

Observed names: N Laferrière, N. Laferriere, N. Laferrière, N.B. Laferriere, Nicole B. Laferriere, Nicole B. Laferrière, Nicole Beatrice Laferriere

Institutions: Thunder Bay Regional Research Institute, Canadian Hematology Society, NOSM University

Observed institutions: Cleveland Clinic, Uniformed Services University of the Health Sciences, University of Ottawa, Utrecht University, Thunder Bay Regional Health Sciences Centre, Institut Gustave Roussy, The Netherlands Cancer Institute, University Medical Center Utrecht, Institute for Biological Sciences, Thunder Bay Regional Research Institute, Centre Léon Bérard, National Research Council Canada, Canadian Hematology Society, Bayer (Germany), Lakehead University, NOSM University

OpenAlex ID: A5050487413

Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma

2009 · Bernard Escudier, Cezary Szczylik, et al. · Journal of Clinical Oncology · 494

Telehealth in Oncology: ASCO Standards and Practice Recommendations

2021 · Robin T. Zon, Erin B. Kennedy, et al. · JCO Oncology Practice · 153

Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer

2009 · Giulia Bianchi, Sibylle Loibl, et al. · Anti-Cancer Drugs · 116

Tubulin synthesis and assembly in differentiating neurons

1997 · N.B. Laferriere, T.H. MacRae, et al. · Biochemistry and Cell Biology · 83

The Efficacy and Safety of Flexible-Dose Vardenafil (Levitra®) in a Broad Population of European Men

2004 · Dimitrios Hatzichristou, Francesco Montorsi, et al. · European Urology · 80

Glutamate-Treated Rat Cortical Neuronal Cultures Die in a Way Different from the Classical Apoptosis Induced by Staurosporine

1997 · John P. MacManus, Ingrid Rasquinha, et al. · Experimental Cell Research · 62

Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial

2021 · Monika K Krzyzanowska, Jim A Julian, et al. · BMJ · 50

PDF

Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study

2013 · P. Hilliard, N. Zourikian, et al. · Journal of Thrombosis and Haemostasis · 48

Vardenafil Improves Satisfaction Rates, Depressive Symptomatology, and Self-Confidence in a Broad Population of Men with Erectile Dysfunction

2005 · Dimitrios Hatzichristou, Beatrice Cuzin, et al. · The Journal of Sexual Medicine · 48

Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort

2018 · Brian M Feldman, Georges E Rivard, et al. · The Lancet Haematology · 38

The molecular basis of microtubule stability in neurons.

1994 · M M Falconer, A Vaillant, et al. · PubMed · 33

Expanding Urgent Oncofertility Services for Reproductive Age Women Remote from a Tertiary Level Fertility Centre by Use of Telemedicine and an On-site Nurse Navigator

2019 · Rhonda Zwingerman, Karen Melenchuk, et al. · Journal of Cancer Education · 31

Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study

2020 · Saunya Dover, Victor S. Blanchette, et al. · Research and Practice in Thrombosis and Haemostasis · 30

PDF

Expression and posttranslational modification of class III β-tubulin during neuronal differentiation of P19 embryonal carcinoma cells

1996 · Nicole B. Laferrière, David L. Brown · Cell Motility and the Cytoskeleton · 28

Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study

2017 · Tanya Skamene, Michael Crump, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 25

Efficacy and safety of intrapatient dose escalation of sorafenib as first-line treatment for metastatic renal cell carcinoma (mRCC).

2011 · M. E. Gore, R. J. Jones, et al. · Journal of Clinical Oncology · 24

Antagonism of N-Methyl-d-aspartate-evoked Currents in Rat Cortical Cultures by ARL 15896AR

1997 · G.A.R. Mealing, T.H. Lanthorn, et al. · Journal of Pharmacology and Experimental Therapeutics · 18

Experience with central venous access devices ( CVAD s) in the Canadian hemophilia primary prophylaxis study ( CHPS )

2015 · A. R. Langley, A. M. Stain, et al. · Haemophilia · 16

Access to Cancer Care in Northwestern Ontario—A Population-Based Study Using Administrative Data

2020 · M. Febbraro, M. Conlon, et al. · Current Oncology · 13

PDF

Phase I Evaluation of Telatinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Irinotecan and Capecitabine in Patients with Advanced Solid Tumors

2010 · Marlies H.G. Langenberg, Petronella O. Witteveen, et al. · Clinical Cancer Research · 13

PDF

A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma

2019 · Michael Sebag, Nizar Bahlis, et al. · Blood · 12

Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group

2015 · Shireen Sirhan, Lambert Busque, et al. · Clinical Lymphoma Myeloma & Leukemia · 12

Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study

2021 · Jennifer Stimec, Saunya Dover, et al. · Research and Practice in Thrombosis and Haemostasis · 11

PDF

Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer

2019 · Monika K. Krzyzanowska, Cassandra MacKay, et al. · Pilot and Feasibility Studies · 11

PDF

Treatment of Dysthymia With Low-dose Amisulpride Versus Amineptine

1992 · P. Boyer, Y. Lecrubier, et al. · Clinical Neuropharmacology · 11

Works count: 40

Citation count: 1,510

H-index: 17

I10-index: 25